Roche’s emicizumab haemophilia drug succeeds in trial
1 year, 9 months ago
SHANGHAI: Roche Holding AG's emicizumab drug for treating haemophilia A showed it worked in a phase III study, the Swiss drugmaker said on Thursday.
Roche is hoping to win a slice of the $11 billion-a-year haemophilia drug market with…